This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations by Peter Y Tu in Biodegradable Stents
Introduction
Peter Y Tu is an accomplished inventor based in Irvine, CA (US). He has made significant contributions to the field of medical devices, particularly in the development of drug-eluting stents. His innovative approach focuses on enhancing the treatment of vulnerable plaques in patients, which is crucial for improving cardiovascular health.
Latest Patents
Peter Y Tu holds a patent for a "Drug-eluting stent having collagen drug carrier chemically treated with genipin." This invention outlines a method for treating vulnerable plaques in patients. The method involves providing a biodegradable stent that consists of a first supporting zone made of a biodegradable material and a second therapeutic zone containing at least one bioactive agent. The stent is designed to be delivered to vulnerable plaques, with the therapeutic zone oriented at the luminal surface to effectively release the bioactive agent for treatment.
Career Highlights
Throughout his career, Peter Y Tu has demonstrated a commitment to advancing medical technology. His work on biodegradable stents showcases his dedication to improving patient outcomes through innovative solutions. With 1 patent to his name, he continues to contribute to the field of medical devices.
Collaborations
Peter has collaborated with notable colleagues, including Hsing-Wen Sung and Mei-Chin Chen. Their combined expertise has likely played a role in the successful development of innovative medical solutions.
Conclusion
Peter Y Tu's contributions to the field of medical devices, particularly through his patented innovations, highlight his role as a significant inventor. His work in developing biodegradable stents represents a meaningful advancement in the treatment of cardiovascular conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile